Cargando…
Deleterious Impact of a Novel CFH Splice Site Variant in Atypical Hemolytic Uremic Syndrome
Atypical hemolytic uremic syndrome (aHUS) is a heterogeneous disorder characterized by microangiopathic hemolytic anemia (MAHA), thrombocytopenia, and acute kidney injury (AKI). In about 50% of cases, pathogenic variants in genes involved in the innate immune response including complement factors co...
Autores principales: | Schönauer, Ria, Seidel, Anna, Grohmann, Maik, Lindner, Tom H., Bergmann, Carsten, Halbritter, Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6530248/ https://www.ncbi.nlm.nih.gov/pubmed/31156713 http://dx.doi.org/10.3389/fgene.2019.00465 |
Ejemplares similares
-
CFH-CFHR1 hybrid genes in two cases of atypical hemolytic uremic syndrome
por: Sugawara, Yuka, et al.
Publicado: (2023) -
Effective immunosuppressive management with belatacept and eculizumab in post-transplant aHUS due to a homozygous deletion of CFHR1/CFHR3 and the presence of CFH antibodies
por: Münch, Johannes, et al.
Publicado: (2017) -
CFH and CFHR structural variants in atypical Hemolytic Uremic Syndrome: Prevalence, genomic characterization and impact on outcome
por: Piras, Rossella, et al.
Publicado: (2023) -
Acute Progression of Adult-Onset Atypical Hemolytic-Uremic Syndrome due to CFH Mutation: A Case Report
por: Posnik, Bartlomiej, et al.
Publicado: (2013) -
Plasma resistant atypical hemolytic uremic syndrome associated with a CFH mutation treated with eculizumab: a case report
por: Sevinc, Mustafa, et al.
Publicado: (2015)